1st Global Advisors’s AbbVie ABBV Stock Holding History

1st Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$3.41M	Sell	47,027 -768	-2%	-$51.6K	0.39%	32
2017 Q1	$3.11M	Buy	47,795 +587	+1%	+$36.9K	0.36%	34
2016 Q4	$2.96M	Buy	47,208 +6,059	+15%	+$370K	0.37%	33
2016 Q3	$2.6M	Sell	41,149 -696	-2%	-$45.1K	0.34%	34
2016 Q2	$2.59M	Sell	41,845 -1,037	-2%	-$63.2K	0.36%	32
2016 Q1	$2.45M	Buy	42,882 +5,419	+14%	+$302K	0.35%	30
2015 Q4	$2.22M	Sell	37,463 -5,370	-13%	-$309K	0.34%	33
2015 Q3	$2.33M	Sell	42,833 -152	-0.4%	-$9.89K	0.37%	29
2015 Q2	$2.89K	Sell	42,985 -1,183	-3%	-$77.2K	0.43%	25
2015 Q1	$2.59M	Buy	+44,168	New	+$2.67M	0.38%	28

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

1st Global Advisors's ABBV Position: Q2 2017 in Review

1st Global Advisors reduced its AbbVie (ABBV) stake by 1.6% in Q2 2017, selling an estimated $51.6K and leaving 47,027 shares worth $3.41M. The position accounts for 0.39% of the portfolio, ranked #32.

1st Global Advisors first reported a position in ABBV in Q1 2015 and has held it in 10 quarters since. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

1st Global Advisors held 47,027 shares of AbbVie worth $3.41M as of Q2 2017.
1st Global Advisors sold 768 AbbVie shares in Q2 2017, an estimated $51.6K.
AbbVie made up 0.39% of 1st Global Advisors's portfolio in Q2 2017, its #32 holding.
1st Global Advisors first reported a position in AbbVie in Q1 2015 and has held it in 10 quarters since.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.